1 / 12

Advanced Hepatocellular and Renal Cell Carcinomas: Updated Data in Specific Patient Populations

Advanced Hepatocellular and Renal Cell Carcinomas: Updated Data in Specific Patient Populations Based on presentations from the 44th Annual Meeting of the American Society of Clinical Oncology (ASCO) May 30-June 3, 2008 Chicago, Illinois. Responses to Sorafenib According to Resistance.

velvet
Download Presentation

Advanced Hepatocellular and Renal Cell Carcinomas: Updated Data in Specific Patient Populations

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Advanced Hepatocellular and Renal Cell Carcinomas: Updated Data in Specific Patient Populations Based on presentations from the 44th Annual Meeting of the American Society of Clinical Oncology (ASCO) May 30-June 3, 2008 Chicago, Illinois

  2. Responses to Sorafenib According to Resistance

  3. Toxicities Developed After Sorafenib Treatment (n=29)

  4. Cardiac-related Grade ≥3 Adverse Events

  5. Cost-effectiveness Results

  6. RECIST Response by ECOG PS

  7. SHARP: Baseline Patient Characteristics

  8. SHARP: RECIST Response Stratified by MVI and/or EHS

More Related